Practical aspects of weekly docetaxel administration schedules.
about
Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancerA phase I pharmacological and biological study of PI-88 and docetaxel in patients with advanced malignancies.Docetaxel does not impair skeletal muscle force production in a murine model of cancer chemotherapyPhase ii trial of a metronomic schedule of docetaxel and capecitabine with concurrent celecoxib in patients with prior anthracycline exposure for metastatic breast cancer.Safety and efficacy of single-agent docetaxel (Taxotere) administered weekly in non-small cell lung carcinoma patients in Korea: An observational study.Dexamethasone premedication for prophylaxis of taxane toxicities: can the doses be reduced when paclitaxel or docetaxel are given weekly?Awareness of the adverse effects associated with prophylactic corticosteroid use during docetaxel therapy.A phase I study of docetaxel, oxaliplatin, & capecitabine (DOC) as first-line therapy of patients with locally advanced or metastatic adenocarcinoma of stomach and GE junction.Evaluation of the effects and adverse drug reactions of low-dose dexamethasone premedication with weekly docetaxel.The impact of docetaxel-related toxicities on health-related quality of life in patients with metastatic cancer (QoliTax).Concurrent chemoradiotherapy with low-dose docetaxel inhibits the growth of DU-145 prostate cancer xenografts.Metastatic extramammary Paget's disease successfully controlled with tumour dormancy therapy using docetaxel.Pharmacogenetic effects of regulatory nuclear receptors (PXR, CAR, RXRα and HNF4α) on docetaxel disposition in Chinese nasopharyngeal cancer patients.Phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer.Safe dose reduction of steroid pre-medication for docetaxel in head and neck neoplasm treatment.Phase II trial of weekly Docetaxel, Zoledronic acid, and Celecoxib for castration-resistant prostate cancer.
P2860
Q24657308-2D458AE2-AF6A-49C9-9622-A9F7959C5F84Q33378865-332AC2C2-574B-4997-9553-321960F1C942Q33800180-72F5BF3F-740D-497E-8605-8A1E7B0250E9Q35872701-78A4BC9E-B258-45BC-91D4-D896CAC0E788Q36636822-14756014-42E3-4512-8CC4-CEF9C44039D5Q37909780-52B1237C-DFA0-47B4-9662-F7A42671B0B9Q38286988-2381AA3E-5798-4CC9-A0F4-5EF07BB61FAEQ39837978-CAC5BE51-CCD9-4DF2-AAF6-8A5DB0A7C9B0Q40521965-75E33F2A-00B7-4A04-827A-5AC7B4ADCC9AQ41441022-0633275D-ABE9-44E2-BDFB-3C73DF8631FAQ44456846-A136F50C-3C53-4F64-A3CB-7F12FBD2CB40Q46909339-5D57ECEA-FE95-4148-A9AB-142B66EE4049Q50053868-B2961770-5AFB-466D-9611-1435FBE1F9A5Q50512926-35B8B434-B199-4AF1-B30A-799DE2AF464BQ53663283-6B429E29-0B5D-4588-A4FD-4981EB00F229Q53786874-8584ECA8-05CF-4890-8852-B0598517E5FA
P2860
Practical aspects of weekly docetaxel administration schedules.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Practical aspects of weekly docetaxel administration schedules.
@ast
Practical aspects of weekly docetaxel administration schedules.
@en
type
label
Practical aspects of weekly docetaxel administration schedules.
@ast
Practical aspects of weekly docetaxel administration schedules.
@en
prefLabel
Practical aspects of weekly docetaxel administration schedules.
@ast
Practical aspects of weekly docetaxel administration schedules.
@en
P1433
P1476
Practical aspects of weekly docetaxel administration schedules.
@en
P304
P356
10.1634/THEONCOLOGIST.9-5-538
P577
2004-01-01T00:00:00Z